In a landmark move to address the complex challenges facing rare disease patients, the U.S. Food and Drug Administration (FDA) has...

Real World Evidence (RWE) is rapidly emerging as a powerful tool to complement traditional clinical trials in drug development and...

The Council for International Organizations of Medical Sciences (CIOMS) has taken a significant step forward in shaping the future of...

The South African Healt h Products Regulatory Authority (SAHPRA) has introduced new guidelines to expedite the approval process for...